Fatty liver index as an indicator of metabolic syndrome

被引:26
|
作者
Rogulj, Dinko [2 ]
Konjevoda, Pasko [3 ]
Milic, Mirta [4 ]
Mladinic, Marin [4 ]
Domijan, Ana-Marija [1 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia
[2] Polyclin Sunce, Zagreb, Croatia
[3] Rudjer Boskovic Inst, NMR Ctr, Zagreb, Croatia
[4] Inst Med Res & Occupat Hlth, Mutagenesis Unit, Zagreb 41000, Croatia
关键词
Fatty liver index; Metabolic syndrome; Oxidative stress; REPTree and SimpleCART algorithms; ROC curve analysis; C-REACTIVE PROTEIN; COMET ASSAY; DNA-DAMAGE; GAMMA-GLUTAMYLTRANSFERASE; OXIDATIVE DAMAGE; NATIONAL-HEALTH; ASSOCIATION; MARKERS; OBESITY; REPAIR;
D O I
10.1016/j.clinbiochem.2011.10.014
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: The aim of this study was to find an early indicator of metabolic syndrome (MetS). Design and methods: We measured several anthropometric, biochemical, haematological, and oxidative damage parameters in 128 middle-aged Caucasian men divided into two groups: patients with MetS (n=69) and healthy controls (n=59), and used Weka REPTree and SimpleCART algorithms to identify the most reliable predictor of MetS. Results: Oxidative damage parameters did not differ between the groups, suggesting that oxidative damage is less prominent at the early stage of MetS. The algorithms singled out fatty liver index (FLI) as the best variable for discriminating between healthy and MetS subjects. This finding was confirmed by the receiver-operating characteristic (ROC) curve analysis, which set FLI 68.53 as the threshold value for MetS diagnosis. Conclusions: FLI is the most reliable tool for diagnosing MetS. The absence of oxidative damage does not rule out oxidative stress but may indicate that MetS is at an early stage. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 50 条
  • [21] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    Han, A. Lum
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [22] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    A Lum Han
    Diabetology & Metabolic Syndrome, 14
  • [23] Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
    Sinn, Dong Hyun
    Kang, Danbee
    Choi, Sung Chul
    Hong, Yun Soo
    Zhao, Di
    Guallar, Eliseo
    Park, Yewan
    Cho, Juhee
    Gwak, Geum-Youn
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1873 - +
  • [24] Non alcoholic fatty liver disease and metabolic syndrome
    Paschos, P.
    Paletas, K.
    HIPPOKRATIA, 2009, 13 (01) : 9 - 19
  • [25] Fatty liver disease: the hepatic manifestation of metabolic syndrome
    Gastaldelli, Amalia
    HYPERTENSION RESEARCH, 2010, 33 (06) : 546 - 547
  • [26] Metabolic profiles in dairy cows with fatty liver syndrome
    Pechová, A
    Illek, J
    Pavlata, L
    WIENER TIERARZTLICHE MONATSSCHRIFT, 2002, 89 (11): : 325 - 332
  • [27] Fitness and metabolic syndrome in obese fatty liver children
    Martins, Clarice
    Pizarro, Andreia
    Aires, Luisa
    Silva, Gustavo
    Silva, Francisco
    Mota, Jorge
    Santos, Maria Paula
    ANNALS OF HUMAN BIOLOGY, 2013, 40 (01) : 99 - 101
  • [28] Nonalcoholic fatty liver and metabolic syndrome in hypopituitary patients
    Williamson-Baddorf, S.
    Nyenwe, E.
    Waters, B.
    Solomon, S. S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 461 - 461
  • [29] A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
    Targher, Giovanni
    Byrne, Christopher D.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (06) : 235 - 238
  • [30] Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
    Kim, Chin Hee
    Younossi, Zair M.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2008, 75 (10) : 721 - 728